Navigation Links
USC research IDs potential treatment for deadly, HIV-related blood cancer
Date:6/25/2013

LOS ANGELES Researchers at the USC Norris Comprehensive Cancer Center have discovered a promising new way to treat a rare and aggressive blood cancer most commonly found in people infected with HIV.

The USC team shows that a class of drugs called BET bromodomain inhibitors effectively targets primary effusion lymphoma (PEL), a type of cancer for which those drugs were not expected to be effective.

"It's a reversal of the paradigm," said Preet Chaudhary, MD, PhD, chief of the Nohl Division of Hematology and Blood Diseases at the Keck School of Medicine of USC and principal investigator of the study. "Our results suggest that this new class of drug may be an effective treatment for a wider range of cancers than previously thought."

PEL is caused by infection with Kaposi's sarcoma-associated herpes virus, the most common cause of cancer among patients with AIDS. The prognosis for PEL is poor, with a median survival of three to six months. Thus, there is a critical need for new therapies for the disease.

Chaudhary and his colleagues show that inhibitors targeting the BRD4 protein blocked growth of PEL cells in a test tube and in a mouse model. The results were surprising because BET inhibitors were thought to be only effective against cancers linked to an overexpression of the Myc gene.

"We actually found that cancers that overexpress Myc are not as responsive to BRD4 inhibitors. PEL is more responsive," Chaudhary said.

Cancers like multiple myeloma and Burkitt's lymphoma overexpress the Myc gene and have been shown to respond to BRD4 inhibitors. In PEL, the Myc gene is moderately expressed and there is no chromosomal translocation as is seen in multiple myeloma or Burkitt's.

More research is needed to create compounds ready for testing in people. Once those drugs are ready for clinical trial, data from this study suggest that they may treat a wide range of cancers. Chaudhary anticipates testing them alone and in combination with other drugs.


'/>"/>

Contact: Alison Trinidad
alison.trinidad@usc.edu
323-442-3941
University of Southern California - Health Sciences
Source:Eurekalert

Related medicine news :

1. MS researchers determine that brain reserve independently protects against cognitive decline in MS
2. New screening approach identifies small proteins unique to melanoma cells, Moffitt researcher says
3. American Brain Tumor Association’s 2013 Patient & Family Conference Highlights Emerging Research
4. Voices Against Brain Cancer Comments on Recent Discovery in Ongoing Brain Cancer Research
5. Ethanol Leads Renewable Chemicals Market; Polymers Sector 14.3% CAGR Growth Forecasted by 2018 Says New Research Report at ReportsnReports.com
6. Arthrex, Depuy Mitek, and Smith & Nephew Lead the $1.5 Billion U.S. Orthopedic Soft Tissue Market, Reports iData Research
7. Citrus, Banana and Other Fruit Growing in Australia Industry Market Research Report Now Updated by IBISWorld
8. Notre Dame and Harper researchers developing novel method to test for HPV and oral cancers
9. Going to synagogue is good for health and happiness, Baylor researcher finds
10. Consider a text for teen suicide prevention and intervention, research suggests
11. America will never be gay and lesbian friendly, says researcher
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... , ... February 21, 2017 , ... Ray Insurance Agencies, ... in and around Tarrant County, is embarking on a six month charity event aimed ... treatments for cancer. , Cancer is one of the deadliest diseases in America; more ...
(Date:2/21/2017)... ... February 21, 2017 , ... Each ... Black History Month (officially African American History Month ). This ... society of a diverse race of people, but also the opportunity to examine ...
(Date:2/21/2017)... ... 2017 , ... A February 6 article on Healio describes a ... that the treatments have led to significant improvements in weight loss and other health ... also noted very few problematic results relating to the treatment. Beverly Hills Physicians (BHP) ...
(Date:2/20/2017)... (PRWEB) , ... February 20, 2017 , ... MRI screening ... to a new study from Germany published online in the journal Radiology . ... that offers better sensitivity than mammography and ultrasound. Currently, guidelines reserve breast MRI screening ...
(Date:2/20/2017)... Fla. (PRWEB) , ... February 20, 2017 , ... Scrubbing ... Cancer Center in Houston, Dr. Christopher Pezzi remembers the excitement of the surgeon training ... believe they pay us to do this? Don’t tell anyone, but I would do ...
Breaking Medicine News(10 mins):
(Date:2/21/2017)... FALLS, Idaho , Feb. 21, 2017  International ... has completed a private placement with certain investors for ... stock of the Company, Series C Convertible Redeemable Preferred ... accrues dividends at an annual rate of 6% and ... The Company plans to use the proceeds for operating ...
(Date:2/21/2017)... Feb. 21, 2017 Research and Markets has announced ... - 2016" report to their offering. ... The latest research Liver Cirrhosis Drugs Price Analysis and ... Liver Cirrhosis market. The research answers the following questions: ... and their clinical attributes? How are they positioned in the Global Liver ...
(Date:2/20/2017)... Resonance Imaging (MRI) Systems Market Outlook to 2022 ... GlobalData,s ... 2022", provides key market data on the EU5 Magnetic Resonance Imaging ... dollars, volume (in units) and average prices (USD) within market segements ... The report also provides company shares and distribution shares data for ...
Breaking Medicine Technology: